Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 26 (RNA5SP26) is classified as a pseudogene of the 5S ribosomal RNA gene family, meaning it is a nonfunctional DNA sequence that resembles the functional 5S rRNA gene but has lost its ability to code for a functional ribosomal RNA due to genomic mutations. The 5S rRNA gene encodes a small RNA that plays a structural and functional role in the ribosome, essential for protein synthesis. However, RNA5SP26 lacks the capacity to produce a stable or functional RNA product and is not incorporated into ribosomes. Pseudogenes like RNA5SP26 may occasionally be transcribed or serve as raw material for regulatory RNAs, but for this locus, no such function or direct implication in disease or therapy has been described.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 26 (RNA5SP26).